32 related articles for article (PubMed ID: 34590740)
21. An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, or Follicular Lymphoma.
Falchi L; Ferrajoli A; Jacobs I; Nava-Parada P
Clin Lymphoma Myeloma Leuk; 2018 Aug; 18(8):508-518.e14. PubMed ID: 29934061
[TBL] [Abstract][Full Text] [Related]
22. Obinutuzumab with Bendamustine for Treating Follicular Lymphoma Refractory to Rituximab: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Rafia R; Pandor A; Davis S; Stevens JW; Harnan S; Clowes M; Sorour Y; Cutting R
Pharmacoeconomics; 2018 Oct; 36(10):1143-1151. PubMed ID: 29594951
[TBL] [Abstract][Full Text] [Related]
23. Enteroviruses in X-Linked Agammaglobulinemia: Update on Epidemiology and Therapy.
Bearden D; Collett M; Quan PL; Costa-Carvalho BT; Sullivan KE
J Allergy Clin Immunol Pract; 2016; 4(6):1059-1065. PubMed ID: 26883540
[TBL] [Abstract][Full Text] [Related]
24. Disseminated enterovirus infection in a patient treated with obinutuzumab.
McNeil T; Hannah R; Hui CH; Qiao M
J Med Virol; 2022 Feb; 94(2):439-441. PubMed ID: 34590740
[No Abstract] [Full Text] [Related]
25. Disseminated Enterovirus Infection in a Patient Affected by Follicular Lymphoma Treated with Obinutuzumab: A Case Report and a Narrative Review of the Literature.
Lupia T; Corcione S; Staffilano E; Bosio R; Curtoni A; Busca A; De Rosa FG
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541221
[No Abstract] [Full Text] [Related]
26. The role of obinutuzumab in the management of follicular lymphoma.
O'Nions J; Townsend W
Future Oncol; 2019 Nov; 15(31):3565-3578. PubMed ID: 31538821
[TBL] [Abstract][Full Text] [Related]
27. Enteroviral infection in patients treated with rituximab for non-Hodgkin lymphoma: a case series and review of the literature.
Grisariu S; Vaxman I; Gatt M; Elias S; Avni B; Arad A; Pasvolsky O; Raanani P; Paltiel O
Hematol Oncol; 2017 Dec; 35(4):591-598. PubMed ID: 27734521
[TBL] [Abstract][Full Text] [Related]
28. Obinutuzumab in follicular lymphoma.
Martinez-Calle N; Figueroa-Mora R; Villar-Fernandez S; Marcos-Jubilar M; Panizo C
Drugs Today (Barc); 2016 Dec; 52(12):643-651. PubMed ID: 28276536
[TBL] [Abstract][Full Text] [Related]
29. Obinutuzumab: A Review in Rituximab-Refractory or -Relapsed Follicular Lymphoma.
Dhillon S
Target Oncol; 2017 Apr; 12(2):255-262. PubMed ID: 28324270
[TBL] [Abstract][Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
